Neurogene Inc. · NASDAQ:NGNE
Casdin Capital, LLC reported a 8.70% stake in Neurogene Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Casdin Capital, LLC reported a 8.70% stake in Neurogene Inc., 1,295,361 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 8.70%
- Shares
- 1,295,361
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Casdin Capital, LLC | 8.70% | 1,295,361 |
| Casdin Partners Master Fund, L.P. | 7.20% | 1,075,000 |
| Casdin Partners GP, LLC | 7.20% | 1,075,000 |
| Eli Casdin | 8.70% | 1,295,361 |
Source
Related
- Neurogene Inc.
- Casdin Capital, LLC
- Neurogene Inc. shareholders
- Schedule 13G · Prudential Financial Inc · Oct 7, 2026
- Schedule 13G · Jennison Associates LLC · Oct 6, 2026
- Form 4 · McMinn Rachel · Oct 2, 2026
- Schedule 13G/A · Redmile Group, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026